1. Executive Summary 2. United States - Molecular Diagnostics Market, Test Volume and Forecast (2010 - 2020) 2.1 United States - Molecular Diagnostics Market and Forecast 2.2 United States - Molecular Diagnostics Test Volume and Forecast 3. United States - Molecular Diagnostics Market and Volume Share (2010 - 2020) 3.1 United States - Application Wise Molecular Diagnostics Market Share and Forecast 3.2 United States - Company Wise Molecular Diagnostics Market Share and Forecast 3.3 United States Molecular Diagnostics Test Volume Share and Forecast - Application Wise 4. United States Molecular Diagnostics Market and Forecast - Application Wise 4.1 Oncology Testing Market (2004 - 2020) 4.1.1 Breast Cancer Testing Market (2004 - 2020) 4.1.2 Colorectal Cancer Testing Market (2004 - 2020) 4.1.3 Prostate Cancer Testing Market (2004 - 2020) 4.1.4 Other Cancer Testing Market (2004 - 2020) 4.2 Infectious Disease Testing Market (2010 - 2020) 4.2.1 Virology Testing Market (2007 - 2020) 4.2.2 HPV Testing Market (2004 - 2020) 4.2.3 HAI Testing Market (2010 - 2020) 4.2.4 Critical Care Testing Market (2010 - 2020) 4.3 Genetic Testing Market (2010 - 2020) 4.4 Blood Screening Market (2006 - 2020) 4.5 Food Pathogen Testing Market (2010 - 2020) 4.6 Tissue Typing (HLA) Testing Market (2008 - 2020) 5. United States Molecular Diagnostics Test Volume - Application Wise 5.1 Oncology Test Volume (2004 - 2020) 5.1.1 Breast Cancer Test Volume (2004 - 2020) 5.1.2 Colorectal Cancer Test Volume (2004 - 2020) 5.1.3 Prostate Cancer Test Volume (2004 - 2020) 5.1.4 Other Cancer Test Volume (2004 - 2020) 5.2 Infectious Disease Test Volume (2010 - 2020) 5.2.1 Virology Test Volume (2007 - 2020) 5.2.2 HPV Test Volume (2004 - 2020) 5.2.3 HAI Test Volume (2010 - 2020) 5.2.4 Critical Care Test Volume (2010 - 2020) 5.3 Genetic Testing Test Volume and Forecast (2010 - 2020) 5.4 Blood Screening Test Volume and Forecast (2006 - 2020) 5.5 Food Pathogen Test Volume and Forecast (2010 - 2020) 5.6 HLA Test Volume and Forecast (2008 - 2020) 6. United States Molecular Diagnostics Market - Company Wise 6.1 Roche - United States Molecular Diagnostic Sales and Forecast 6.2 Abbott Laboratories - United States Molecular Diagnostic Sales and Forecast 6.3 Myriad Genetics - United States Molecular Diagnostic Sales and Forecast 6.4 Biomerieux - United States Molecular Diagnostic Sales and Forecast 6.5 Qiagen - United States Molecular Diagnostic Sales and Forecast 6.6 Hologic Inc. (Acquired Gen-Probe) - United States Molecular Diagnostic Sales and Forecast 6.7 Becton Dickinson - United States Molecular Diagnostic Sales and Forecast 6.8 Siemens - United States Molecular Diagnostic Sales and Forecast 6.9 Cepheid - United States Molecular Diagnostic Sales and Forecast 6.10 Others - United States Molecular Diagnostic Sales and Forecast 7. United States Molecular Diagnostics Market - Driving Factors 7.1 Increasing Automation to Drive the Molecular Diagnostics Market 7.2 Investment in Genomics and Proteomics Research 7.3 Personalized Medicine Fuels Molecular Diagnostics 8. United States Molecular Diagnostics Market - Challenges 8.1 Regulatory Issues 8.2 Reimbursement Capabilities 8.3 Quality Checkpoints, Awareness and Acceptance

List of Figures: Figure 2-1: United States - Molecular Diagnostics Market (Million US$), 2010 - 2014 Figure 2-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2015 - 2020 Figure 2-3: United States - Molecular Diagnostics Test Volume (Million), 2010 - 2014 Figure 2-4: United States - Forecast for Molecular Diagnostics Test Volume (Million), 2015 - 2020 Figure 3-1: United States - Molecular Diagnostics Applications Market Share (Percent), 2010 - 2014 Figure 3-2: United States - Forecast for Molecular Diagnostics Applications Market Share (Percent), 2015 - 2020 Figure 3-3: United States - Company Wise Molecular Diagnostics Market Share (Percent), 2010 - 2014 Figure 3-4: United States - Forecast for Company Wise Molecular Diagnostics Market Share (Percent), 2015 - 2020 Figure 3-5: United States - Molecular Diagnostics Applications Test Volume Share (Percent), 2010 - 2014 Figure 3-6: United States - Forecast for Molecular Diagnostics Applications Test Volume Share (Percent), 2015 - 2020 Figure 4-1: United States - Molecular Diagnostic Oncology Testing Market (Million US$), 2004 - 2014 Figure 4-2: United States - Forecast for Molecular Diagnostic Oncology Testing Market (Million US$), 2015 - 2020 Figure 4-3: United States - Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2004 - 2014 Figure 4-4: United States - Forecast for Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2015 - 2020 Figure 4-5: United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2004 - 2014 Figure 4-6: United States - Forecast for Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2015 - 2020 Figure 4-7: United States - Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2004 - 2014 Figure 4-8: United States - Forecast for Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2015 - 2020 Figure 4-9: United States - Other Molecular Diagnostic Cancer Testing Market (Million US$), 2004 - 2014 Figure 4-10: United States - Forecast for Other Molecular Diagnostic Cancer Testing Market (Million US$), 2015 - 2020 Figure 4-11: United States - Infectious Disease Testing Market (Million US$), 2010 - 2014 Figure 4-12: United States - Forecast for Infectious Disease Testing Market (Million US$), 2015 - 2020 Figure 4-13: United States - Virology Testing Market (Million US$), 2007 - 2014 Figure 4-14: United States - Forecast for Virology Testing Market (Million US$), 2015 - 2020 Figure 4-15: United States - HPV Testing Market (Million US$), 2004 - 2014 Figure 4-16: United States - Forecast for HPV Testing Market (Million US$), 2015 - 2020 Figure 4-17: United States - HAI Testing Market (Million US$), 2010 - 2014 Figure 4-18: United States - Forecast for HAI Testing Market (Million US$), 2015 - 2020 Figure 4-19: United States - Critical Care Testing Market (Million US$), 2010 - 2014 Figure 4-20: United States - Forecast for Critical Care Testing Market (Million US$), 2015 - 2020 Figure 4-21: United States - Genetic Testing Market (Million US$), 2010 - 2014 Figure 4-22: United States - Forecast for Genetic Testing Market (Million US$), 2015 - 2020 Figure 4-23: United States - Blood Screening Market (Million US$), 2006 - 2014 Figure 4-24: United States - Forecast for Blood Screening Market (Million US$), 2015 - 2020 Figure 4-25: United States - Food Pathogen Testing Market (Million US$), 2010 - 2014 Figure 4-26: United States - Forecast for Food Pathogen Testing Market (Million US$), 2015 - 2020 Figure 4-27: United States - HLA Testing Market (Million US$), 2008 - 2014 Figure 4-28: United States - Forecast for HLA Testing Market (Million US$), 2015 - 2020 Figure 5-1: United States - Oncology Test Volume (Million), 2004 - 2014 Figure 5-2: United States - Forecast for Oncology Test Volume (Million), 2015 - 2020 Figure 5-3: United States - Breast Cancer Test Volume (Million), 2004 - 2014 Figure 5-4: United States - Forecast for Breast Cancer Test Volume (Million), 2015 - 2020 Figure 5-5: United States - Colorectal Cancer Test Volume (Million), 2004 - 2014 Figure 5-6: United States - Forecast for Colorectal Cancer Test Volume (Million), 2015 - 2020 Figure 5-7: United States - Prostate Cancer Test Volume (Million), 2004 - 2014 Figure 5-8: United States - Forecast for Prostate Cancer Test Volume (Million), 2015 - 2020 Figure 5-9: United States - Other Cancer Test Volume (Million), 2004 - 2014 Figure 5-10: United States - Forecast for Other Cancer Test Volume (Million), 2015 - 2020 Figure 5-11: United States - Infectious Disease Test Volume (Million), 2010 - 2014 Figure 5-12: United States - Forecast for Infectious Disease Test Volume (Million), 2015 - 2020 Figure 5-13: United States - Virology Test Volume (Million), 2007 - 2014 Figure 5-14: United States - Forecast for Virology Test Volume (Million), 2015 - 2020 Figure 5-15: United States - HPV Test Volume (Million), 2004 - 2014 Figure 5-16: United States - Forecast for HPV Test Volume (Million), 2015 - 2020 Figure 5-17: United States - HAI Test Volume (Million), 2010 - 2014 Figure 5-18: United States - Forecast for HAI Test Volume (Million), 2015 - 2020 Figure 5-19: United States - Critical Care Test Volume (Million), 2010 - 2014 Figure 5-20: United States - Forecast for Critical Care Test Volume (Million), 2015 - 2020 Figure 5-21: United States - Genetic Testing Test Volume (Million), 2010 - 2014 Figure 5-22: United States - Forecast for Genetic Testing Test Volume (Million), 2015 - 2020 Figure 5-23: United States - Blood Screening Test Volume (Million), 2006 - 2014 Figure 5-24: United States - Forecast for Blood Screening Test Volume (Million), 2015 - 2020 Figure 5-25: United States - Food Pathogen Test Volume (Million), 2010 - 2014 Figure 5-26: United States - Forecast for Food Pathogen Test Volume (Million), 2015 - 2020 Figure 5-27: United States - HLA Test Volume (Million), 2008 - 2014 Figure 5-28: United States - Forecast for HLA Test Volume (Million), 2015 - 2020 Figure 6-1: Roche - United States Molecular Diagnostic Sales (Million US$), 2008 - 2014 Figure 6-2: Roche - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-3: Abbott Laboratories - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-4: Abbott Laboratories - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-5: Myriad Genetics - United States Molecular Diagnostic Sales (Million US$), 2007 - 2014 Figure 6-6: Myriad Genetics - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-7: Biomerieux - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-8: Biomerieux - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-9: Qiagen - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-10: Qiagen - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-11: Hologic-Gen-Probe - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-12: Hologic-Gen-Probe - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-13: Becton Dickinson - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-14: Becton Dickinson - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-15: Siemens - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-16: Siemens - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-17: Cepheid - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-18: Cepheid - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 6-19: Others - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014 Figure 6-20: Others - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020 Figure 7-1: United States - Investment in the Human Genome Project (Billion US$), 2003, 2012